does the va cover glp-1 drugs Research TRICARE Coverage of Weight Loss
Description
doi: 10.1530/ERC-12-0111 [DOI] [PubMed] [Google Scholar] 21
Medicare is not allowed to cover weight-loss drugs under current law and Medicaid coverage varies by state
JAMA 331 , 384824945 (2024)
The primary outcome of the trial was the change in A1C from baseline at week 26
Tirzepatide achieved significant reductions in Glycated Hemoglobin A1c (HbA1c) levels and body weight compared to placebo
The primary outcome was the mean HbA1c change from baseline to 56 weeks, which was significantly reduced in both semaglutide groups against sitagliptin
